Cited by 542Birth, Development, and HealthPregnancy and preeclampsia studiesGestational Diabetes Research and Management

Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches

Jansson, Thomas, Powell, Theresa L.·2007·Clinical Science

Abstract

Adverse influences during fetal life alter the structure and function of distinct cells, organ systems or homoeostatic pathways, thereby ‘programming’ the individual for an increased risk of developing cardiovascular disease and diabetes in adult life. Fetal programming can be caused by a number of different perturbations in the maternal compartment, such as altered maternal nutrition and reduced utero–placental blood flow; however, the underlying mechanisms remain to be fully established. Perturbations in the maternal environment must be transmitted across the placenta in order to affect the fetus. Here, we review recent insights into how the placenta responds to changes in the maternal environment and discuss possible mechanisms by which the placenta mediates fetal programming. In IUGR (intrauterine growth restriction) pregnancies, the increased placental vascular resistance subjects the fetal heart to increased work load, representing a possible direct link between altered placental structure and fetal programming of cardiovascular disease. A decreased activity of placental 11β-HSD-2 (type 2 isoform of 11β-hydroxysteroid dehydrogenase) activity can increase fetal exposure to maternal cortisol, which programmes the fetus for later hypertension and metabolic disease. The placenta appears to function as a nutrient sensor regulating nutrient transport according to the ability of the maternal supply line to deliver nutrients. By directly regulating fetal nutrient supply and fetal growth, the placenta plays a central role in fetal programming. Furthermore, perturbations in the maternal compartment may affect the methylation status of placental genes and increase placental oxidative/nitrative stress, resulting in changes in placental function. Intervention strategies targeting the placenta in order to prevent or alleviate altered fetal growth and/or fetal programming include altering placental growth and nutrient transport by maternally administered IGFs (insulin-like growth factors) and altering maternal levels of methyl donors.

Integrity signals

Registry

Crossref · 10.1042/cs20060339

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • GDM is associated with increased System A and L activity.

    “GDM is associated with increased System A and L activity [150].”

    From The Pathophysiology of Gestational Diabetes Mellitus (2018) · cites this paper as [150]

  • The placenta is a central integrative organ because it senses and responds to maternal nutrients, hormones, inflammatory mediators and environmental agents through vascular, transport, endocrine and molecular functions.

    “The placenta is a central integrative organ because it senses and responds to maternal nutrients, hormones, inflammatory mediators and environmental agents through vascular, transport, endocrine and molecular functions [140,141,142].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Jansson, T., & Powell, T. L.
Affiliations
University of Cincinnati (US)
Venue
Clinical Science
Published
2007-06-01
Volume
113
Issue
1
Pages
1-13
ISSN
  • 0143-5221 (ISSN-L)
  • 1470-8736
OpenAlex
W1994919529
Cited by
542
References
9
Citations by year
2026: 23 · 2025: 20 · 2024: 27 · 2023: 30 · 2022: 23 · 2021: 36 · 2020: 34 · 2019: 21 · 2018: 40 · 2017: 31 · 2016: 24 · 2015: 30 · 2014: 29 · 2013: 38 · 2012: 38
FWCI
3.29
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Science (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
Keywords
placenta, fetal programming, fetal growth restriction, placental vascular resistance, 11β-hydroxysteroid dehydrogenase type 2, maternal cortisol, hypertension, placental nutrient transport, oxidative stress, insulin-like growth factor, maternal nutrition, uteroplacental blood flow, placental development
MeSH terms
Biological Transport, Female, Humans, Maternal-Fetal Exchange, Placenta, Pregnancy, Prenatal Exposure Delayed Effects, Oxidative Stress, Prenatal Nutritional Physiological Phenomena, 11-beta-Hydroxysteroid Dehydrogenases, Fetal Development

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review